68Ga-HA-DOTATATE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 68Ga-HA-DOTATATE, covering 2025-05-07 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors [Phase 2]